Anthill said Anthill Cloud is now available in the US for pharmaceutical, biotech and medtech commercial and medical teams. The company describes the platform as an AI-powered content-excellence system for life sciences.
Anthill said Anthill Cloud is now available in the US for pharmaceutical, biotech and medtech commercial and medical teams.
The company announced the launch on May 18, 2026, saying the platform is designed as a life-sciences content-supply-chain system that combines AI-powered content creation, modular authoring and omnichannel HCP engagement.
Anthill describes Anthill Cloud as its content excellence platform for life sciences. The product page says it is built to support connected content workflows across the industry’s commercial and medical teams.
The US availability marks a market expansion for the platform. Anthill’s announcement did not include named US customers or pilot deployments.
The launch adds another option in a category of software aimed at helping life-sciences companies create and manage regulated content more efficiently.
Revision note
Initial automated publication.